Showing results (151-160 of 181) with videos related to
Sort By:
Pageof 19
European Endocrinology|April 11, 2018
Neonatal Screening for Congenital Hypothyroidism with Focus on Developing an Indian Screening ProgrammeJubbin Jagan JacobEuropean Endocrinology|April 11, 2018
Latest Developments and Future Perspectives in the Field Of ObesityBelén Pérez-Pevida, Alexander D MirasEuropean Endocrinology|April 11, 2018
Pilot Study of a Web-based Decision Tool on Post-operative Use of Radioactive IodineShrujal S Baxi, Rachel Kurtzman, Anne Eaton, et al.European Endocrinology|April 11, 2018
The Vildagliptin Experience - 25 Years Since the Initiation of the Novartis Glucagon-like Peptide-1 Based Therapy Programme and 10 Years Since the First Vildagliptin RegistrationJames E Foley, Bo AhrénEuropean Endocrinology|April 11, 2018
Dipeptidyl Peptidase-4 Inhibitor Development and Post-authorisation Programme for Vildagliptin - Clinical Evidence for Optimised Management of Chronic Diseases Beyond Type 2 DiabetesWilliam David Strain, Päivi M PaldániusEuropean Endocrinology|April 11, 2018
An Economic Evaluation of Continuous Glucose Monitoring for People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia within North West London Clinical Commissioning Groups in EnglandShraddha Chaugule, Nick Oliver, Brigitte Klinkenbijl, et al.European Endocrinology|April 11, 2018
Ranibizumab in Diabetic Macular Oedema - A Benefit-risk Analysis of Ranibizumab 0.5 mg PRN Versus Laser TreatmentFocke Ziemssen, Alan Cruess, Cornelia Dunger-Baldauf, et al.European Endocrinology|June 7, 2018
A Patient-level Analysis of Efficacy and Hypoglycaemia Outcomes Across Treat-to-target Trials with Insulin Glargine Added to Oral Antidiabetes Agents in People with Type 2 DiabetesJ Hans DeVries, Luigi Meneghini, Anthony H Barnett, et al.European Endocrinology|June 7, 2018
Resveratrol for the Management of Diabetes and its Downstream PathologiesMoola Joghee Nanjan, James BetzPageof 19